Scalzo et al. found that serum levels of IL-6 were markedly increased in patients with PD and that PD patients who exhibited higher serum levels of IL-6 demonstrated a reduced gait speed, more problems in performing tasks that required postural changes and reduced base support, indicating that IL-6 may be associated with motion function in patients with PD [43]. The gene discussed is IL6; the disease is Parkinson disease.